These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1023 related articles for article (PubMed ID: 30976107)

  • 1. Applications of machine learning in drug discovery and development.
    Vamathevan J; Clark D; Czodrowski P; Dunham I; Ferran E; Lee G; Li B; Madabhushi A; Shah P; Spitzer M; Zhao S
    Nat Rev Drug Discov; 2019 Jun; 18(6):463-477. PubMed ID: 30976107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery.
    Yang X; Wang Y; Byrne R; Schneider G; Yang S
    Chem Rev; 2019 Sep; 119(18):10520-10594. PubMed ID: 31294972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of machine learning approaches for novel drug discovery.
    Lima AN; Philot EA; Trossini GH; Scott LP; Maltarollo VG; Honorio KM
    Expert Opin Drug Discov; 2016; 11(3):225-39. PubMed ID: 26814169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine Learning in Drug Discovery: A Review.
    Dara S; Dhamercherla S; Jadav SS; Babu CM; Ahsan MJ
    Artif Intell Rev; 2022; 55(3):1947-1999. PubMed ID: 34393317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From machine learning to deep learning: progress in machine intelligence for rational drug discovery.
    Zhang L; Tan J; Han D; Zhu H
    Drug Discov Today; 2017 Nov; 22(11):1680-1685. PubMed ID: 28881183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The In Silico Drug Discovery Toolbox: Applications in Lead Discovery and Optimization.
    Bruno A; Costantino G; Sartori L; Radi M
    Curr Med Chem; 2019; 26(21):3838-3873. PubMed ID: 29110597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A compact review of progress and prospects of deep learning in drug discovery.
    Li H; Zou L; Kowah JAH; He D; Liu Z; Ding X; Wen H; Wang L; Yuan M; Liu X
    J Mol Model; 2023 Mar; 29(4):117. PubMed ID: 36976427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into Machine Learning-based Approaches for Virtual Screening in Drug Discovery: Existing Strategies and Streamlining Through FP-CADD.
    Hussain W; Rasool N; Khan YD
    Curr Drug Discov Technol; 2021; 18(4):463-472. PubMed ID: 32767944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep Transferable Compound Representation across Domains and Tasks for Low Data Drug Discovery.
    Abbasi K; Poso A; Ghasemi J; Amanlou M; Masoudi-Nejad A
    J Chem Inf Model; 2019 Nov; 59(11):4528-4539. PubMed ID: 31661955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced machine-learning techniques in drug discovery.
    Elbadawi M; Gaisford S; Basit AW
    Drug Discov Today; 2021 Mar; 26(3):769-777. PubMed ID: 33290820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of machine learning in GPCR bioactive ligand discovery.
    Jabeen A; Ranganathan S
    Curr Opin Struct Biol; 2019 Apr; 55():66-76. PubMed ID: 31005679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Machine learning for synergistic network pharmacology: a comprehensive overview.
    Noor F; Asif M; Ashfaq UA; Qasim M; Tahir Ul Qamar M
    Brief Bioinform; 2023 May; 24(3):. PubMed ID: 37031957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliable Prediction Errors for Deep Neural Networks Using Test-Time Dropout.
    Cortés-Ciriano I; Bender A
    J Chem Inf Model; 2019 Jul; 59(7):3330-3339. PubMed ID: 31241929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics.
    Koromina M; Pandi MT; Patrinos GP
    OMICS; 2019 Nov; 23(11):539-548. PubMed ID: 31651216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilizing graph machine learning within drug discovery and development.
    Gaudelet T; Day B; Jamasb AR; Soman J; Regep C; Liu G; Hayter JBR; Vickers R; Roberts C; Tang J; Roblin D; Blundell TL; Bronstein MM; Taylor-King JP
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34013350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of drug candidates and repurposing opportunities through compound-target interaction networks.
    Cichonska A; Rousu J; Aittokallio T
    Expert Opin Drug Discov; 2015 Dec; 10(12):1333-45. PubMed ID: 26429153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could advances in representation learning in Artificial Intelligence provide the new paradigm for data integration in drug discovery?
    Vijayan V; Rouillard AD; Rajpal DK; Agarwal P
    Expert Opin Drug Discov; 2019 Mar; 14(3):191-194. PubMed ID: 30696299
    [No Abstract]   [Full Text] [Related]  

  • 18. Artificial intelligence for dementia drug discovery and trials optimization.
    Doherty T; Yao Z; Khleifat AAL; Tantiangco H; Tamburin S; Albertyn C; Thakur L; Llewellyn DJ; Oxtoby NP; Lourida I; ; Ranson JM; Duce JA
    Alzheimers Dement; 2023 Dec; 19(12):5922-5933. PubMed ID: 37587767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep Learning in Drug Discovery.
    Gawehn E; Hiss JA; Schneider G
    Mol Inform; 2016 Jan; 35(1):3-14. PubMed ID: 27491648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based drug design with geometric deep learning.
    Isert C; Atz K; Schneider G
    Curr Opin Struct Biol; 2023 Apr; 79():102548. PubMed ID: 36842415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.